Methotrexate hepatotoxicity in psoriatics: Report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up

Canadian Journal of Gastroenterology

Volumn 10, Issue 6, 1996, Pages 369-375

  Malatjalian, D A ^a,b   Ross, J B ^a   Williams, C N ^a   Colwell, S J ^a   Eastwood, B J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Alcohol consumption; Diabetes; Hepatotoxicity; Liver biopsy; Methotrexate; Psoriatics

Indexed keywords

ALCOHOL; FOLIC ACID ANTAGONIST; METHOTREXATE;

ADOLESCENT; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANADA; CHILD; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PSORIASIS; RETROSPECTIVE STUDY; RISK; SCHOOL CHILD;

EID: 0029958053     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1996/213596     Document Type: Article

References (27)

1. Roenigk HH Jr, Haserick JR, Curtis GH. Methotrexate for psoriasis. Cleve Clin Q 1963;3:211-5.
2. Hanno R, Gruber GG, Owen LG, Callen JP. Methotrexate in psoriasis: a brief review of indications, usage, and complications of methotrexate therapy. J Am Acad Dermatol 1980;2:171-4.
3. Roenigk HH Jr, Haserick JR, Curtis GH. Methotrexate for psoriasis. Cleve Clin J Med 1983;50:101-5.
4. Weinstein GD. Commentary: three decades of folic acid antagonists in dermatology. Arch Dermatol 1983;119:525-7.
5. Edmundson G, Guy W. Treatment of psoriasis with folic acid antagonist. Arch Dermatol 1958;78:200-3.
6. Weinstein G, Roenigk HH, Maibach H, Cosmides J, Halprin K, Millard M. Psoriasis-liver-methotrexate interactions. Arch Dermatol 1973;103:35-42.
7. Ashton RE, Millward-Sadler GH, White JE. Complications in methotrexate treatment of psoriasis with particular reference to liver fibrosis. J Invest Dermatol 1982;79:229-32.
8. Zachariae H, Kragballe K, Sogaard H. Methotrexate induced liver cirrhosis: studies including serial liver biopsies during continued treatment. Br J Dermatol 1980;102:407-12.
9. Roenigk HH Jr, Maibach HI, Weinstein G. Guidelines on methotrexate therapy for psoriasis. Arch Dermatol 1972;105:363-5.
10. Roenigk HH Jr, Maibach HI, Weinstein G. Methotrexate therapy for psoriasis: guidelines revisions. Arch Dermatol 1973;108:36-42.
11. Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein G. Methotrexate guidelines: revised. J Am Acad Dermatol 1982;6:145-55.
12. Roenigk HH Jr, Auerbach R, Maibach HI, Weinstein G. Methotrexate in psoriasis: revised guidelines. J Am Acad Dermatol 1988;19:145-56.
13. Nyfors A. Liver biopsies from psoriatics related to methotrexate therapy. Acta Pathol Microbiol Immunol Scand 1977;85:511-8.
14. O'Keefe QEW, Fye KH, Sack KD. Methotrexate and histologic hepatic abnormalities: a meta-analysis. Am J Med 1991;90:711-6.
15. Newman M, Auerbach R, Feiner H, et al. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Arch Dermatol 1989;125:1218-24.
16. O'Connor GT, Olmstead EM, Zug K, et al. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis. Arch Dermatol 1989;125:1209-17.
17. Agresti A. Categorical Data Analysis. New York: John Wiley and Sons, 1990:84-91.
18. Zachariae H, Sogaard H. Methotrexate induced liver cirrhosis: a follow-up. Dermatologica 1987;175:178-82.
19. Gilbert SC, Klintmalm G, Mentor A, Silverman A. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this "steroid-sparing" agent. Arch Intern Med 1990;150:889-91.
20. Reese LT, Grisham JW, Aach RD, Eisen AZ. Effect of methotrexate on the liver in psoriasis. J Invest Dermatol 1974;62:597-602.
21. Zachariae H, Grunnet E, Sogaard H. Liver biopsy in methotrexate-treated psoriasis - a re-evaluation. Acta Derm Venereol (Stockh) 1975;55:291-6.
22. Van de Kerhof PCM, Hoefnagels WHL, Van Haelst UJGM, Mali JWH. Methotrexate maintenance therapy and liver damage in psoriasis. Clin Exp Dermatol 1985;10:194-200.
23. Health and Public Policy Committee, American Collage of Physicians. Position Paper: methotrexate in rheumatoid arthritis. Ann Intern Med 1987;107:418-9.
24. Kremer JM, Koff R. A debate: Should patients with rheumatoid arthritis on methotrexate undergo liver biopsies? Semin Arthritis Rheum 1992;21:376-86.
25. Nyfros A, Poulsen H. Liver biopsies from psoriatics related to methotrexate therapy. Acta Pathol Microbiol Immunol Scand 1976;84:262-70.
26. Alder M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 1979;67:811-6.
27. Tobias H, Auerbach R. Hepatotoxicity of long-term methotrexate therapy for psoriasis. Arch Intern Med 1973;132:391-6.